Literature DB >> 12736875

Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait.

Olivier Rémy-Néris1, Vincent Tiffreau, Stéphane Bouilland, Bernard Bussel.   

Abstract

OBJECTIVE: To determine whether leg muscle stiffness is measurably reduced after intrathecal baclofen (ITB) in subjects with spastic hemiplegia.
DESIGN: Nonrandomized trial.
SETTING: Inpatient multidisciplinary rehabilitation unit in France. PARTICIPANTS: Seven consecutive subjects with spastic hemiplegia having Ashworth Scale scores for their quadriceps and triceps greater than 2. INTERVENTION: Subjects were given ITB by lumbar puncture after a dose-selecting test period. MAIN OUTCOME MEASURES: Triceps and quadriceps Ashworth scores, gait analysis at preferred and maximal speed measured by a motion analysis system with 2 forceplates, and electromyographic recording of leg muscles before and 4 hours after ITB. The slopes of the moment-angle curves were measured on the hemiplegic side at the onset of ankle and knee flexion to assess muscle stiffness during walking. Pre- and post-ITB spatiotemporal, kinetic, and kinematic data were compared by using a nonparametric test (Wilcoxon signed-rank test).
RESULTS: Ashworth scores of the quadriceps and triceps of all subjects decreased significantly after ITB. Maximal walking speed increased significantly, with a significant increase in stride length, but the preferred walking speed was unchanged. Minimal knee extension and maximal ankle flexion were the only kinematic data significantly different (increased) after ITB. The slope of the ankle moment-angle curve decreased significantly after ITB at preferred gait speed; it also decreased at maximal gait speed in all but 1 subject. Of the 4 available moment-angle curves, 3 showed decreased knee extensor muscle stiffness. The duration of the bursts of spastic muscles decreased after ITB.
CONCLUSION: Acute ITB improved walking and reduced muscle stiffness at both the ankles and knees on the spastic hemiplegic side of our subjects. Electromyographic findings suggest that some of the post-ITB reduction in muscle stiffness might be attributed to decreased spasticity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736875     DOI: 10.1016/s0003-9993(02)04906-7

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  7 in total

1.  [Intrathecal baclofen therapy in ambulatory patients with spastic hemiparesis following stroke. Short report of two cases].

Authors:  S Kästner
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

2.  Prolonged quadriceps activity following imposed hip extension: a neurophysiological mechanism for stiff-knee gait?

Authors:  Michael D Lewek; T George Hornby; Yasin Y Dhaher; Brian D Schmit
Journal:  J Neurophysiol       Date:  2007-09-26       Impact factor: 2.714

Review 3.  Intrathecal baclofen for childhood hypertonia.

Authors:  A Leland Albright
Journal:  Childs Nerv Syst       Date:  2007-06-29       Impact factor: 1.475

Review 4.  New clinical and research trends in lower extremity management for ambulatory children with cerebral palsy.

Authors:  Diane L Damiano; Katharine E Alter; Henry Chambers
Journal:  Phys Med Rehabil Clin N Am       Date:  2009-08       Impact factor: 1.784

5.  Identification of intrinsic and reflex ankle stiffness components in stroke patients.

Authors:  Laura Galiana; Joyce Fung; Robert Kearney
Journal:  Exp Brain Res       Date:  2005-07-01       Impact factor: 1.972

6.  Effect of the Intrathecal Baclofen Screening Test on the Spatiotemporal Gait Motion Parameters of Patients with Cervical Spinal Cord Injuries Who Exhibited Diffuse Spasticity: A Report of Three Cases.

Authors:  Ippei Kitade; Hidetaka Arishima; Ken-Ichiro Kikuta
Journal:  NMC Case Rep J       Date:  2014-06-19

7.  Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS).

Authors:  Michael Creamer; Geoffrey Cloud; Peter Kossmehl; Michael Yochelson; Gerard E Francisco; Anthony B Ward; Jörg Wissel; Mauro Zampolini; Abdallah Abouihia; Nathalie Berthuy; Alessandra Calabrese; Meghann Loven; Leopold Saltuari
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-01-11       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.